Luspatercept in patients with non-transfusion dependent β-thalassaemia

Lancet Haematol. 2022 Oct;9(10):e709-e711. doi: 10.1016/S2352-3026(22)00256-3. Epub 2022 Aug 22.

Authors

Uwe Platzbecker¹, Jessica Kate Morison²

Affiliations

¹ University Medical Center Leipzig, Department of Hematology and Cellular Therapy, University of Leipzig, Leipzig 04109, Germany. Electronic address: uwe.platzbecker@medizin.uni-leipzig.de.
² University Medical Center Leipzig, Department of Hematology and Cellular Therapy, University of Leipzig, Leipzig 04109, Germany.

PMID: 36007539
DOI: 10.1016/S2352-3026(22)00256-3

No abstract available

Publication types

Comment

MeSH terms

Activin Receptors, Type II
Humans
Immunoglobulin Fc Fragments / therapeutic use
Recombinant Fusion Proteins / therapeutic use
beta-Thalassemia* / drug therapy

Substances

Immunoglobulin Fc Fragments
Recombinant Fusion Proteins
luspatercept
Activin Receptors, Type II